MedPath

Femtosecond Small Incision Lenticular Extraction in Comparison to Femtosecond Laser Insitu Keratomileusis Regarding Dry Eye Disease

Not Applicable
Completed
Conditions
Dry Eye Disease
Interventions
Procedure: FS-SMILE
Procedure: S-LASIK
Registration Number
NCT04477421
Lead Sponsor
Al-Rasheed University College
Brief Summary

Comparison of femtosecond small incision lenticule extraction (FS-SMILE) versus Femtosecond laser Insitu Keratomileusis (FS-LASIK) regarding dry eye disease (DED) and corneal sensitivity (CS) after those refractive surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • bilateral eyes with spherical correction range from -2 to -6 diopters and cylinder range from 0 to - 3.5 diopters
Exclusion Criteria
  • sign or symptom of dry eye disease (tear film breakup time (TBUT) >10 seconds
  • Schirmer I test >10 mm /5 minutes)
  • corneal or conjunctival staining
  • Meibomian gland dysfunction
  • Previous ocular and or eyelid medical or surgical treatment
  • pregnancy
  • Chronic systemic disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FS-SMILEFS-SMILE100 eyes of 50 patients who underwent bilateral FS-SMILE (femtosecond small incision lenticule extraction)
FS-LASIK GroupS-LASIK100 eyes of 50 patients underwent bilateral FS-LASIK (Femtosecond laser Insitu Keratomileusis)
Primary Outcome Measures
NameTimeMethod
Oxford scoreAfter 6 months of surgery

Oxford score (the score range from 0 to 5), higher value indicate more severe disease

Schirmer I testAfter 6 months of surgery

Schirmer I test (in mm/5 minutes)

Tear Break-Up TimeAfter 6 months of surgery

Tear Break-Up Time (in seconds)

Dry Eye Work Shop scaleAfter 6 months of surgery

Dry Eye Work Shop scale (value range from 0 to 4), higher value indicate more severe disease

Ocular Surface Disease IndexAfter 6 months of surgery

Ocular Surface Disease Index (the index range from 0 to 100), higher value indicate more severe disease

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al-Rasheed University College

🇮🇶

Baghdad, AL-Adhmia, Iraq

© Copyright 2025. All Rights Reserved by MedPath